Engineers Gate Manager LP Geron Corp Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $6,847 - $12,826	-3,476 Reduced 23.53%	11,295 $36,000
Q1 2023 May 15, 2023	SELL	$2.14 - $3.4 $7,984 - $12,685	-3,731 Reduced 20.17%	14,771 $32,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $37,559 - $44,774	18,502 New	18,502 $44,000
Q2 2022 Aug 15, 2022	SELL	$1.19 - $1.65 $38,776 - $53,765	-32,585 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $32,259 - $52,136	32,585 New	32,585 $44,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.